| SMS Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532815 |
NSE Symbol : SMSPHARMA |
P/E(TTM) : 36.94 |
|
ISIN Demat : INE812G01025 |
Div & Yield% : 0.11 |
EPS(TTM) : 9.67 |
|
Book Value(₹) : 85.93 |
Market Cap(₹Cr) : 3,345.25 |
Face Value(₹) : 1.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 206.96 | 237.95 | 210.45 | 242.43 | 196.05 | 248.20 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 206.96 | 237.95 | 210.45 | 242.43 | 196.05 | 248.20 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 1.74 | 2.57 | 3.75 | 1.43 | 0.59 | 1.42 |
| Total Income | 208.71 | 240.52 | 214.20 | 243.86 | 196.64 | 249.62 |
| Total Expenditure | 165.07 | 198.07 | 166.65 | 194.05 | 157.19 | 206.85 |
| PBIDT | 43.63 | 42.45 | 47.55 | 49.81 | 39.45 | 42.77 |
| Interest | 5.50 | 5.28 | 6.22 | 5.74 | 5.84 | 5.07 |
| PBDT | 38.14 | 37.18 | 41.32 | 44.08 | 33.61 | 37.70 |
| Depreciation | 9.99 | 10.13 | 10.02 | 10.02 | 9.75 | 8.64 |
| Tax | 6.10 | 5.43 | 7.25 | 8.25 | 5.00 | 4.65 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.91 | 0.69 | 0.72 | 0.66 | 0.65 | 3.79 |
| Reported Profit After Tax | 21.13 | 20.92 | 23.34 | 25.14 | 18.21 | 20.62 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 21.13 | 20.92 | 23.34 | 25.14 | 18.21 | 20.62 |
| EPS (Unit Curr.) | 2.26 | 2.29 | 2.57 | 2.82 | 2.05 | 2.43 |
| EPS (Adj) (Unit Curr.) | 2.26 | 2.29 | 2.57 | 2.82 | 2.05 | 2.43 |
| Calculated EPS (Unit Curr.) | 2.26 | 2.23 | 2.49 | 2.68 | 2.05 | 2.33 |
| Calculated EPS (Adj) (Unit Curr.) | 2.26 | 2.23 | 2.49 | 2.68 | 2.05 | 2.33 |
| Calculated EPS (Ann.) (Unit Curr.) | 9.03 | 8.94 | 9.97 | 10.74 | 8.22 | 9.30 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 9.03 | 8.94 | 9.97 | 10.74 | 8.22 | 9.30 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 9.37 | 9.37 | 9.37 | 9.37 | 8.87 | 8.87 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 21.08 | 17.84 | 22.59 | 20.55 | 20.12 | 17.23 |
| PBDTM(%) | 18.43 | 15.63 | 19.63 | 18.18 | 17.14 | 15.19 |
| PATM(%) | 10.21 | 8.79 | 11.09 | 10.37 | 9.29 | 8.31 |
